Comparison of the effectiveness of proteolytic enzymes and diclofenac in patients with impacted third molars in the mandible.
Not Applicable
- Registration Number
- CTRI/2023/08/056907
- Lead Sponsor
- Dr Ramkrishn Yadav
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Mandibular third molar impacted patients with the similar Pedersons difficulty index.
2)Age group of 18 to 40 years.
3)Patient coming under category of ASA I
4)The medications or anesthetics that will be utilized in the surgical regimen have not contraindications.
5)Patients who are willing to accept informed consent and are willing to participate in the study with its subsequent follow ups will be included in this study.
Exclusion Criteria
1)Patients with systemically compromised health.
2)Pregnant and lactating women.
3)Patients allergic to NSAIDS.
4)Patients on anticoagulant therapy.
5)Patient coming under category of ASA II, III, and IV.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The best drug regimen among proteolytic enzymes with diclofenac in reducing post-operative complication like Pain, Swelling Trismus following Surgical extraction of Mandibular third molarTimepoint: Post operative 1st 3rd 5th 7th days
- Secondary Outcome Measures
Name Time Method pain, swelling, trismus,Timepoint: 0,1,3,5,7 days